Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-330-1 | CAS number: 69227-24-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February 17, 2014 to March 7, 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Amides, C8-18 (even numbered) and C18-unsatd., N-(hydroxyethyl)
- EC Number:
- 931-330-1
- Cas Number:
- 69227-24-3
- Molecular formula:
- The alkyl chain length of the amide ranges between 8 and 18 carbon atoms
- IUPAC Name:
- Amides, C8-18 (even numbered) and C18-unsatd., N-(hydroxyethyl)
- Test material form:
- solid: flakes
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver microsomal enzymes (S9 homogenate)
- Test concentrations with justification for top dose:
- Range finding test in strain TA100 and E.Coli WP2 uvrA with and without metabolic activation: Positive control; Solvent control; 3; 10; 33; 100; 333; 1000; 3330; 5000 ug/L
Experiment 1: Tester trains TA1535, TA1537, TA98 with and without metabolic activation: Positive control; Solvent control; 3; 10; 33; 100; 333; 1000 ug/L.
Experiment 2: Tester trains TA1535, TA1537, TA98, TA100: Positive control; Solvent control; 3; 10; 33; 100; 333; 1000 ug/L. Tester strain E.Coli WP2 uvrA: Positive control; Solvent control; 3; 10; 33; 100; 333; 1000; 3330 and 5000 ug/L - Vehicle / solvent:
- Ethanol
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Ethanol
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Saline
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- sodium azide
- Remarks:
- TA1535; concentration/plate 5 µg
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- other: ICR-191
- Remarks:
- TA1537; concentration/plate 2.5 µg
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA98; concentration/plate 10 µg
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- TA100; concentration/plate 650 µg
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- Positive controls:
- yes
- Remarks:
- without metabolic activation
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- WP2 uvrA; concentration/plate 15 µg
- Positive controls:
- yes
- Remarks:
- with metabolic activation and solvent DMSO
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- TA1535 2.5 µg S9-mix 5 and 10%; TA1537 2.5 µg S9-mix 5%; TA1537 5 µg S9-mix 10%; TA98 1 µg S9-mix 5 and10%; TA100 1 µg S9-mix 5% ; TA100 2 µg S9-mix 10% ; W2P uvrA 15 µg S9-mix 5 and 10%
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation)
NUMBER OF REPLICATIONS: Triplicates
DETERMINATION OF CYTOTOXICITY: Reduction of the bacterial background lawn, the increase in the size of the microcolonies and the reduction of the revertant colonies were examined. - Evaluation criteria:
- A Salmonella typhimurium reverse mutation assay and/or Escherichia coli reverse mutation assay is considered acceptable if it meets the following criteria:
a)The negative control data (number of spontaneous revertants per plate) should be within the laboratory historical range for each tester strain
b)The positive control chemicals should produce responses in all tester strains, which are within the laboratory historical range documented for each positive control substance. Furthermore, the mean plate count should be at least three times the concurrent vehicle control group mean
c)The selected dose range should include a clearly toxic concentration or should exhibit limited solubility as demonstrated by the preliminary toxicity range-finding test or should extendto 5 mg/plate.
No formal hypothesis testing was done.
A test substance is considered negative (not mutagenic) in the test if:
a)The total number of revertants in tester strain TA100 is not greater than two (2) times the concurrent control, and the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2 uvrA is not greater than three (3) times the concurrent vehicle control.
b)The negative response should be reproducible in at least one independently repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a)The total number of revertants in tester strain TA100 is greater than two (2) times the concurrent control, or the total number of revertants in tester strains TA1535, TA1537, TA98 or WP2 uvrA is greater than three (3) times the concurrent vehicle control.
b)In case a repeat experiment is performed when a positive response is observed in one of the tester strains, the positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: Cytotoxicity, as evidenced by a decrease in the number of revertants, was observed in tester strain TA98 in the presence of 5 and 10 %(v/v) S9-mix.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Dose range finding test/Experiment 1
The test substance was tested in the tester strains TA100 and WP2 uvrA with concentrations of 3, 10, 33, 100, 333, 1000, 3330 and 5000 µg/plate in the absence and presence of S9-mix. Based on the results of the dose range finding test, the test substance was tested in the first mutation assay at a concentration range of 3 to 666 µg/plate in the absence of S9-mix and at a concentration range of 10 to 1000 µg/plate in the presence of 5% (v/v) S9-mix in the tester strains TA1535, TA1537 and TA98.
Precipitate
Dose range finding test: Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at concentrations of 3330 and 5000 µg/plate. First mutation experiment: Precipitation of the test substance on the plates was observed at the start of the incubation period at concentrations of 666 and 1000 µg/plate and no precipitate was observed at the end of the incubation period. Except in tester strain TA98 where no precipitate was observed at the start or at the end of the incubation period.
Toxicity
To determine the toxicity of the test substance, the reduction of the bacterial background lawn, the increase in the size of the microcolonies and the reduction of the revertant colonies were examined. In tester strain WP2 uvrA, the bacterial background lawn was not reduced at any of the concentrations tested. No biologically relevant decrease in the number of revertants was observed up to the dose level of 3330 μg/plate. Since the test substance precipitated heavily on the plates at the test substance concentration of 5000 μg/plate, the number of revertants of this dose level could not be determined. The reduction of the bacterial background lawn and the reduction in the number of revertants in the other tester strains are presented in Table 1.
Table1: Toxicity of Amides, C8-18(even numbered) and C18 unsatd., N-(hydroxyethyl) in the dose range finding/first experiment
(Reduction of the bacterial background lawn and in the number of revertant colonies)
Strain |
Without S9-mix |
With S9-mix |
|
Dose Bacterial Revertant (μg/plate) background lawn colonies |
Dose Bacterial Revertant (µg/plate) background lawn colonies |
||
TA1535 |
333 moderate -2 666 extreme microcolonies |
333 slight -1 666 slight -2 1000 moderate -2 |
|
TA1537 |
333 moderate -1 666 extreme microcolonies |
333 slight -1 666 slight -2 1000 moderate extreme |
|
TA98 |
666 normal extreme |
1000 normal -2 |
|
TA100 |
333 slight moderate 1000 extreme microcolonies 3330 absent complete 5000 absent -3 |
1000 moderate extreme 3330 absent complete 5000 absent -3 |
|
-1 No reduction in the number of revertant colonies
-2 Reduction in the number of revertant colonies, but not less than the minimal value of the historical control data range.
-3 Due to the amount of precipitate no colony determination was possible
Experiment 2
To obtain more information about the possible mutagenicity of the test substance, a second mutation experiment was performed in the absence of S9-mix and in the presence of 10% (v/v) S9-mix. Based on the results of the first mutation assay, the following dose range was selected for the second mutation assay: TA1535, TA1537, TA98, TA100: Without S9-mix: 3, 10, 33, 100, 333 and 666 μg/plate and with S9-mix: 10, 33, 100, 333, and 1000 μg/plate WP2 uvrA: Without and with S9-mix: 10, 33, 100, 333, 1000 and 3300 µg/plate.
Precipitate
Precipitation of the test substance on the plates was only observed in tester strain WP2 uvrA at the start of the incubation period at concentrations of 1000 and 3330 µg/plate in the absence of S9-mix and at 3330 µg/plate in the presence of S9-mix. At the end of the incubation period, precipitation on the plates was only observed at 3330 µg/plate in the absence of S9-mix.
Toxicity
In tester strain WP2 uvrA, no reduction of the bacterial background lawn and no biologically relevant decrease in the number of revertants were observed. The reduction of the bacterial background lawn and the reduction in the number of revertants in the other tester strains is presented in Table 2.
Table2: Toxicity of the test substance in second experiment (Reduction of the bacterial background lawn and in the number of revertant colonies)
Strain |
Without S9-mix |
With S9-mix |
|
Dose Bacterial Revertant (μg/plate) background lawn colonies |
Dose Bacterial Revertant (µg/plate) background lawn colonies |
||
TA1535 |
333 moderate -2 666 extreme absent |
1000 moderate -1 |
|
TA1537 |
333 slight moderate 666 extreme microcolonies |
1000 normal -2 |
|
TA98 |
666 moderate extreme |
1000 normal moderate |
|
TA100 |
100 slight moderate 333 moderate extreme 1000 extreme microcolonies |
333 normal moderate 666 moderate extreme 1000 moderate extreme |
|
-1 No reduction in the number of revertant colonies
-2 Reduction in the number of revertant colonies, but not less than the minimal value of the historical control data range.
Experiment 3
In the first experiment in tester strain TA98 and in the second experiment in the tester strains TA1537 and WP2 uvrA no toxicity or precipitate on the plates was observed in the presence of S9-mix. Therefore a third mutation experiment was performed with these strains and tester strain TA98 in the presence of S9-mix at a concentration range of 333 to 5000 µg/plate.
Precipitate
Precipitation of the test substance on the plates was observed at the start and at the end of the incubation period at concentrations of 3330 and 5000 µg/plate.
Toxicity
Due to precipitate of the test substance on the plates the bacterial background could not be determined at the dose levels of 3330 and 5000 μg/plate, except at tester strain WP2 uvrA. Cytotoxicity, as evidenced by a decrease in the number of revertants, was observed in tester strain TA98 in the presence of 5 and 10 %(v/v) S9-mix. Mutagenicity In the third mutation assay, no increase in the number of revertants was observed upon treatment with the test substance under all conditions tested.
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, the test substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay.
- Executive summary:
A study was conducted to evaluate the in vitro genetic toxicity of the test substance, C8-18 and C18-unsatd. MEA, according to OECD Guideline 471, in compliance with GLP. The substance was tested in the Salmonella typhimurium reverse mutation assay with four histidine-requiring strains of Salmonella typhimurium (TA1535, TA1537, TA98 and TA100) and in the Escherichia coli reverse mutation assay with a tryptophan-requiring strain of Escherichia coli (WP2 uvrA). The test was performed in two independent experiments in the presence and absence of S9-mix (rat liver S9-mix induced by Aroclor). An additional experiment was performed with the strains TA1537, TA98 and WP2 uvrA in the presence of S9-mix. In the dose range finding test, the substance was tested up to concentrations of 5000 μg/plate in the absence and presence of S9-mix in the strains TA100 and WP2 uvrA. The substance precipitated on the plates at dose levels of 3330 and 5000 μg/plate. In tester strain TA100, toxicity was observed at dose levels of 333 μg/plate and upwards in the absence of S9-mix and at dose levels of 1000 μg/plate and upwards in the presence of S9-mix. In tester strain WP2 uvrA, the bacterial background lawn was not reduced at any of the concentrations tested. No biologically relevant decrease in the number of revertants was observed up to the dose level of 3330 μg/plate. Since the test substance precipitated heavily on the plates at the test substance concentration of 5000 μg/plate, the number of revertant colonies of this dose level could not be determined. Based on the results of the dose range finding test, the substance was tested in the first mutation assay at a concentration range of 3 to 666 μg/plate in the absence of S9-mix and at a concentration range of 10 to 1000 μg/plate in the presence of 5% (v/v) S9-mix in tester strains TA1535, TA1537 and TA98. The test substance did not precipitate on the plates at this dose level. Toxicity was observed in all tester strains, except in TA98 in the presence of S9-mix. In an independent repeat of the assay with additional parameters, the substance was tested at a concentration range of 3 to 666 μg/plate in the absence of S9-mix and at a concentration range of 10 to 1000 μg/plate in the presence of 10% (v/v) S9-mix in tester strains TA1535, TA1537, TA98 and TA100 and at 10 to 3330 μg/plate in tester strain WP2 uvrA in the absence and presence of 10% (v/v) S9-mix. Precipitate on the plates was only observed at the dose level of 3330 μg/plate in the absence of S9-mix. Toxicity was observed in all tester strains, except in TA1537 and TA98 in the presence of S9-mix and in WP2 uvrA in the absence and presence of S9-mix. Since in the first experiment in tester strain TA98 and in the second experiment in the tester strains TA1537, TA98 and WP2 uvrA no toxicity or precipitate on the plates was observed, a third mutation experiment was performed with these strains in the presence of S9-mix (5% %(v/v) S9-mix and 10 %(v/v) S9-mix, for experiment 1 and 2, respectively). The substance was tested up to 5000 μg/plate. The test substance precipitated on the plates at dose levels of 3330 and 5000 μg/plate. Due to the precipitate of the test substance on the plates the bacterial background could not be determined at the dose levels of 3330 and 5000 μg/plate, except at tester strain WP2 uvrA. Cytotoxicity, as evidenced by a decrease in the number of revertants, was observed in tester strain TA98 in the presence of 5 and 10 %(v/v) S9-mix. The substance did not induce a significant dose-related increase in the number of revertant (His+) colonies in each of the four tester strains (TA1535, TA1537, TA98 and TA100) and in the number of revertant (Trp+) colonies in tester strain WP2 uvrA both in the absence and presence of S9-metabolic activation. These results were confirmed in an independently repeated experiment. In this study, the negative and strain-specific positive control values were within the laboratory historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly. Under the study conditions, the test substance was not mutagenic in the Salmonella typhimurium and Escherichia coli reverse mutation assay (Verspeek-Rip, 2014).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.